Follow

Patients with , even when treated with levothyroxine (L-T4), face increased risk of and . Fortunately, the risk can be lowered again by a combination therapy with L-T4 and L-T3, as shown by a recent study.

pubmed.ncbi.nlm.nih.gov/405791

doi.org/10.1210/clinem/dgaf367

Sign in to participate in the conversation
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.